Synthetic microscopic beads sense changes in their environment and self-propel to migrate upstream, a step toward the realization of biomimetic microsystems with the ability to sense and respond to environmental changes.
Researchers at UC San Diego School of Medicine conducted the first population-based study that characterizes the association and temporal relationship between gastrointestinal stromal tumors (GIST) and other cancers. The results, published by Cancer on April 30, indicate that one in 5.8 patients with GIST will develop additional malignancies before and after their diagnosis.
In proof-of-concept experiments, researchers at University of California, San Diego School of Medicine demonstrate the ability to tune medically relevant cell behaviors by manipulating a key hub in cell communication networks. The manipulation of this communication node, reported in this week’s issue of Proceedings of the National Academy of Sciences, makes it possible to reprogram large parts of a cell’s signaling network instead of targeting only a single receptor or cell signaling pathway.
On Saturday, May 2 and Sunday, May 3, the La Jolla Symphony & Chorus will premiere The Moon in La Jolla, the 2015 winner of the prestigious Nee Commission Award. In addition to the classic orchestral ensemble, the UC San Diego Library’s carillon, which sits atop Geisel Library, will make its debut in the La Jolla Symphony performances via telematic technology.
Comet, a new petascale supercomputer designed to transform advanced scientific computing by expanding access and capacity among traditional as well as non-traditional research domains, has transitioned into an early operations phase at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego.
Urinary tract infections (UTIs) are common, and widespread antibiotic resistance has led to urgent calls for new ways to combat them. Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences report that an experimental drug that stabilizes a protein called HIF-1alpha protects human bladder cells and mice against a major UTI pathogen. The drug might eventually provide a therapeutic alternative or complement to standard antibiotic treatment.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
